Some of the names on the move ahead of the open.» Read More
There was a mini-rally and spike in volume in shares of good ol' Dendreon this morning and early afternoon. The run-up occured ahead of CEO Dr. Mitchell Gold's presentation at the BIO CEO conference in New York City at 1:15 ET.
When the economy rebounds, where's your portfolio going to be? UBS says that's a question to answer right now. The bank released what it calls its "'New' Nifty Fifty," a list of 50 companies from around the world that can use today's troubling market conditions to position themselves to thrive when the economy rebounds. (PART 1)
The changes announced Monday have Cramer baffled.Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.
Investors are worried about a recession again. So CNBC asked the experts for some recession-proof stock picks.
The medical device field has its problems -- but Jan Wald thinks the stocks of medical device makers may be excellent defensive plays in the current market environment. "Valuations of these stocks are pretty low at this point," the Stanford Group managing director told CNBC...
Standard and Poor's has just released the results of its twice-a-year stock screen, designed to find Warren Buffett-style stocks. The new list features several tech stocks, including Apple, as well as a number of names from Europe and Asia. But some key Buffett criteria aren't taken into account by the screen.
Stocks closed higher as investors appeared more enthused about Microsoft's bid for Yahoo! than they were concerned about the latest signs of economic weakness. The three major indexes each gained about 3-4 percent for the week, but the market still has a way to go to recover from January's rout.
As the markets continue to swing up and down, some of the biggest names in the Dow Industrials can be snapped up with fairly sizable yields.
Amgen reported on Thursday that its fourth-quarter profit edged higher, on a reversal of declining sales of its anemia drugs that have been hit with safety concerns and new restrictions on their use and insurance reimbursements.
Pfizer Wednesday reported a higher-than-expected fourth-quarter profit, helped by lower taxes, a weak dollar and growing demand for its drugs for nerve pain, kidney cancer and smoking cession.
The surprise rate cut coming from the Federal Reserve appeared to calm investors somewhat after dramatic drops overseas. What's the word on the Street?
A surprise Fed rate cut helped hold back a massive selloff in the stock market, although stocks closed lower on continued worries about the US economy.
Johnson & Johnson said Tuesday its fourth-quarter earnings rose almost 10 percent, beating forecasts, as the weak dollar propelled overseas sales of its drugs, medical devices and consumer products.
The global freefall in equities markets is likely to shake Wall Street Tuesday morning as investors shun stocks and search for safety plays.
"Do as I do, not as I say" That’s, the motto behind a little segment we like to call whale watching where we profile the world's most successful investors - a.k.a whales - and try to find out if you can trade in their wake.
Our traders are good - but you knew that! Check out their latest picks that paid.
Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!
The European Commission raided some of the world's largest drugmakers on Wednesday, launching a broad investigation into whether they made illegal deals or abused patents to limit competition and harm consumers.
Kevin O'Marah, chief strategist at AMR Research, has developed a unique "supply-chain strategy" -- and uses it to compile a Top 25 stocks list that beat the 2007 market hands-down.
Stocks closed sharply higher after a late-session rally as investors piled into sectors seen as resistant to economic contraction, such as health care and staples, amid talk of recession.